A detailed history of Parus Finance (Uk) LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Parus Finance (Uk) LTD holds 12,603 shares of LLY stock, worth $9.78 Million. This represents 3.31% of its overall portfolio holdings.

Number of Shares
12,603
Previous 9,609 31.16%
Holding current value
$9.78 Million
Previous $7.48 Million 52.64%
% of portfolio
3.31%
Previous 2.82%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$724.87 - $909.04 $2.17 Million - $2.72 Million
2,994 Added 31.16%
12,603 $11.4 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $5.69 Million - $7.61 Million
9,609 New
9,609 $7.48 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $738B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Parus Finance (Uk) LTD Portfolio

Follow Parus Finance (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parus Finance (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parus Finance (Uk) LTD with notifications on news.